“…Viruses including Ebola, Marburg, Dengue, Huaiyangshan virus and Crimean-Congo hemorrhagic fever (CCHF) give rise to hemorrhagic fever in the host via multiple mechanisms, including cytokine-mediated endothelial activation and damage, clotting factor consumption and direct hepatic toxicity causing decreased production of clotting factors [42]. Hemorrhagic complications have rarely been noted in infections with non-hemorrhagic viruses such as varicella zoster virus (VZV) [42][43][44][45], cytomegalovirus (CMV) [46][47][48] and Epstein-Barr virus (EBV) [49]. On the other end of the spectrum, thrombotic complications including deep vein thrombosis (DVT), pulmonary embolism (PE), thrombotic microangiopathy (TMA), thrombotic thrombocytopenic purpura (TTP) and portal vein thrombosis have been reported in many viral infections including Avian influenza (H5N1), Swine flu (H1N1), Parvovirus B19, CMV, EBV, VZV, Hepatitis A and Hepatitis C virus and human immunodeficiency virus (HIV) [50].…”